CLBS Annual Cash & Cash Equivalents
$24.65 M
+$8.13 M+49.27%
31 December 2021
Summary:
As of February 3, 2025, CLBS annual cash & cash equivalents is $24.65 million, with the most recent change of +$8.13 million (+49.27%) on December 31, 2021. During the last 3 years, it has risen by +$14.35 million (+139.31%).CLBS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS Quarterly Cash And Cash Equivalents
$31.48 M
-$1.87 M-5.61%
01 September 2022
Summary:
As of February 3, 2025, CLBS quarterly cash and cash equivalents is $31.48 million, with the most recent change of -$1.87 million (-5.61%) on September 1, 2022. Over the past year, it has increased by +$18.71 million (+146.46%).CLBS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +49.3% | +146.5% |
| 3 y3 years | +139.3% | +148.4% |
| 5 y5 years | -15.5% | +108.8% |
CLBS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -46.6% | -31.8% |
Caladrius Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $31.48 M(-5.6%) |
| June 2022 | - | $33.35 M(+161.6%) |
| Mar 2022 | - | $12.75 M(-48.3%) |
| Dec 2021 | $24.65 M(+49.3%) | $24.65 M(+93.0%) |
| Sept 2021 | - | $12.77 M(-1.3%) |
| June 2021 | - | $12.94 M(-55.0%) |
| Mar 2021 | - | $28.74 M(+74.1%) |
| Dec 2020 | $16.51 M(+17.7%) | $16.51 M(-22.0%) |
| Sept 2020 | - | $21.16 M(-20.7%) |
| June 2020 | - | $26.68 M(+28.6%) |
| Mar 2020 | - | $20.75 M(+47.8%) |
| Dec 2019 | $14.03 M(+36.2%) | $14.03 M(+10.7%) |
| Sept 2019 | - | $12.67 M(+7.8%) |
| June 2019 | - | $11.75 M(-18.5%) |
| Mar 2019 | - | $14.42 M(+40.1%) |
| Dec 2018 | $10.30 M(-64.7%) | $10.30 M(-28.4%) |
| Sept 2018 | - | $14.37 M(-36.7%) |
| June 2018 | - | $22.73 M(+5.2%) |
| Mar 2018 | - | $21.60 M(-25.9%) |
| Dec 2017 | $29.16 M(+312.1%) | $29.16 M(+93.4%) |
| Sept 2017 | - | $15.08 M(-34.6%) |
| June 2017 | - | $23.04 M(+92.1%) |
| Mar 2017 | - | $12.00 M(+69.5%) |
| Dec 2016 | $7.08 M(-65.2%) | $7.08 M(-62.0%) |
| Sept 2016 | - | $18.61 M(+5.1%) |
| June 2016 | - | $17.70 M(-30.4%) |
| Mar 2016 | - | $25.43 M(+25.1%) |
| Dec 2015 | $20.32 M(+6.0%) | $20.32 M(-15.5%) |
| Sept 2015 | - | $24.04 M(-33.6%) |
| June 2015 | - | $36.21 M(+89.3%) |
| Mar 2015 | - | $19.13 M(-0.2%) |
| Dec 2014 | $19.17 M(-58.4%) | $19.17 M(-40.3%) |
| Sept 2014 | - | $32.14 M(-2.2%) |
| June 2014 | - | $32.87 M(-20.5%) |
| Mar 2014 | - | $41.36 M(-10.3%) |
| Dec 2013 | $46.13 M(+235.8%) | $46.13 M(+172.2%) |
| Sept 2013 | - | $16.95 M(+15.1%) |
| June 2013 | - | $14.72 M(+59.1%) |
| Mar 2013 | - | $9.25 M(-32.6%) |
| Dec 2012 | $13.74 M(+249.1%) | $13.74 M(+154.8%) |
| Sept 2012 | - | $5.39 M(+155.2%) |
| June 2012 | - | $2.11 M(-90.3%) |
| Mar 2012 | - | $21.77 M(+453.2%) |
| Dec 2011 | $3.94 M(-74.8%) | $3.94 M(-66.4%) |
| Sept 2011 | - | $11.71 M(+141.5%) |
| June 2011 | - | $4.85 M(-48.5%) |
| Mar 2011 | - | $9.41 M(-39.7%) |
| Dec 2010 | $15.61 M | $15.61 M(+283.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $4.07 M(-62.9%) |
| June 2010 | - | $10.96 M(-4.0%) |
| Mar 2010 | - | $11.42 M(+59.5%) |
| Dec 2009 | $7.16 M(+1561.9%) | $7.16 M(+22.4%) |
| Sept 2009 | - | $5.85 M(-44.0%) |
| June 2009 | - | $10.45 M(+2560.3%) |
| Mar 2009 | - | $392.80 K(-8.8%) |
| Dec 2008 | $430.80 K(-81.3%) | $430.80 K(-45.8%) |
| Sept 2008 | - | $794.40 K(+50.1%) |
| June 2008 | - | $529.10 K(-45.4%) |
| Mar 2008 | - | $969.80 K(-57.9%) |
| Dec 2007 | $2.30 M(+427.6%) | $2.30 M(-36.9%) |
| Sept 2007 | - | $3.65 M(+4172.6%) |
| June 2007 | - | $85.40 K(-91.9%) |
| Mar 2007 | - | $1.06 M(+142.5%) |
| Dec 2006 | $436.70 K(-10.7%) | $436.70 K(-66.9%) |
| Sept 2006 | - | $1.32 M(+44.7%) |
| June 2006 | - | $912.30 K(+3035.1%) |
| Mar 2006 | - | $29.10 K(-94.0%) |
| Dec 2005 | $488.90 K(+1652.3%) | $488.90 K(+4601.0%) |
| Sept 2005 | - | $10.40 K(+3366.7%) |
| June 2005 | - | $300.00(-94.4%) |
| Mar 2005 | - | $5400.00(-80.6%) |
| Dec 2004 | $27.90 K(-86.8%) | $27.90 K(-94.0%) |
| Sept 2004 | - | $461.40 K(>+9900.0%) |
| June 2004 | - | $1800.00(-92.4%) |
| Mar 2004 | - | $23.60 K(-88.8%) |
| Dec 2003 | $210.90 K(+992.7%) | $210.90 K(+546.9%) |
| Sept 2003 | - | $32.60 K(+18.5%) |
| June 2003 | - | $27.50 K(+84.6%) |
| Mar 2003 | - | $14.90 K(-22.8%) |
| Dec 2002 | $19.30 K(-62.4%) | $19.30 K(-61.4%) |
| Sept 2002 | - | $50.00 K(+474.7%) |
| June 2002 | - | $8700.00(-79.3%) |
| Mar 2002 | - | $42.00 K(-18.1%) |
| Dec 2001 | $51.30 K(-40.1%) | $51.30 K(-58.6%) |
| Sept 2001 | - | $123.90 K(+64.5%) |
| June 2001 | - | $75.30 K(+65.1%) |
| Mar 2001 | - | $45.60 K(-46.7%) |
| Dec 2000 | $85.60 K(-94.8%) | $85.60 K(-92.5%) |
| Sept 2000 | - | $1.14 M(+5.8%) |
| June 2000 | - | $1.08 M(-29.1%) |
| Mar 2000 | - | $1.53 M |
| Dec 1999 | $1.64 M(+694.7%) | - |
| Dec 1998 | $206.30 K(-81.7%) | - |
| Mar 1998 | $1.13 M(+8453.8%) | - |
| Mar 1997 | $13.20 K(>+9900.0%) | - |
| Mar 1996 | $100.00 | - |
FAQ
- What is Caladrius Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Caladrius Biosciences?
- What is Caladrius Biosciences annual cash & cash equivalents year-on-year change?
- What is Caladrius Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Caladrius Biosciences?
- What is Caladrius Biosciences quarterly cash and cash equivalents year-on-year change?
What is Caladrius Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of CLBS is $24.65 M
What is the all time high annual cash & cash equivalents for Caladrius Biosciences?
Caladrius Biosciences all-time high annual cash & cash equivalents is $46.13 M
What is Caladrius Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, CLBS annual cash & cash equivalents has changed by +$8.13 M (+49.27%)
What is Caladrius Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CLBS is $31.48 M
What is the all time high quarterly cash and cash equivalents for Caladrius Biosciences?
Caladrius Biosciences all-time high quarterly cash and cash equivalents is $46.13 M
What is Caladrius Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, CLBS quarterly cash and cash equivalents has changed by +$18.71 M (+146.46%)